DURHAM, N.C., Sept. 6, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today presentations at the following upcoming investor conferences in September:
Kenneth I. Moch, President and CEO of Chimerix, will present on Monday, September 9, 2013 at 1:15 p.m. EDT at the Grand Hyatt New York in New York City.
Kenneth I. Moch, President and CEO of Chimerix, will present on Wednesday, September 11, 2013 at 8:00 a.m. EDT at the Four Seasons Hotel in Boston.
A live audio webcast of each presentation will be available on the Investor Relations section of Chimerix's website at http://ir.chimerix.com/events.cfm, where it will be archived for 30 days.
Chimerix, a biopharmaceutical company based in Durham, NC, is committed to the discovery, development and commercialization of novel, oral antiviral therapeutics designed to transform patient care in areas of high unmet medical need. Chimerix's proprietary lipid technology has given rise to two clinical-stage nucleotide analog lipid-conjugates, CMX001 and CMX157, which have demonstrated the potential for enhanced activity and safety in convenient, orally administered dosing regimens. CMX001 has shown broad-spectrum activity against double-stranded DNA viruses, including herpesviruses, adenoviruses and polyomaviruses. Chimerix's second product candidate, CMX157, an oral nucleotide analog for the treatment of HIV infection, was licensed to Merck in July 2012.
CONTACT: Joseph T. Schepers Executive Director, Investor Relations 919-287-4125 email@example.com MEDIA CONTACT: Tony Plohoros 908-940-0135 firstname.lastname@example.org
|Zimmer Holdings to Present at Morgan Stanley 2013 Global Healthcare Conference ()|
|Chimerix to Present at 25th Annual Piper Jaffray Healthcare Conference ()|
|Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference 2013 (2013/9/5)|
|EA to Present at Morgan Stanley Technology, Media & Telecom Conference (2014/2/19)|
|Medidata to Present at Morgan Stanley Technology, Media & Telecom Conference (2014/2/25)|
|Millennial Media to Present at Morgan Stanley Technology, Media & Telecom Conference (2014/2/26)|
|Cincinnati Bell to Present at Morgan Stanley Technology, Media & Telecom Conference (2014/2/21)|
|Lattice Semiconductor to Present at Morgan Stanley Technology, Media & Telecom Conference (2014/2/26)|
|Discovery Communications CFO Andrew Warren to Present at Morgan Stanley Technology, Media & Telecom Conference (2014/2/24)|
|Microsemi to Present at Morgan Stanley Technology, Media & Telecom Conference (2014/2/27)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.